When was the last time you asked a patient to contribute to trial design? Have you ever asked a patient to contribute to a protocol? Patient-centricity benefits the entire healthcare ecosystem. The post When Patients Win, Everyone Wins appeared first on MedCity News.
Trump drug price ultimatum.Baumol cost disease: Child care vs. pet care & health care vs. veterinary care editions.Jennifer Doudna interview on CRISPR.AMA on PBMs.Life 30,000 feet underwater.
Pam Austin, CIO of Ballad Health, detailed how her health system is helping clinicians spend less time on screens and more time with patients. The post Ballad Health CIO: Tech Should ‘Fade into the Background’ appeared first on MedCity News.
When Jessica Staten’s kidney stones wouldn’t pass, she said, her doctor suggested a procedure to “blow ’em up.” She went to have it done last November at St. Joseph Medical Center in Bellingham, Washington, one of nine hospitals that the Catholic health system PeaceHealth operates in the Pacific Northwest and Alaska. “I was probably there…
Cedars-Sinai and Redesign Health launched a new innovation center seeking to build digital health startups from the ground up. These startups will focus on four main areas: care access, personalized medicine, provider workflows and care coordination. The post Cedars-Sinai, Redesign Health Launch New Digital Health Startup Builder appeared first on MedCity News.
Novo Nordisk, AbbVie, and Roche each have weekly injectable drug candidates designed to bind to and activate the amylin receptor to trigger weight loss. Metsera’s contender, MET-233i, is designed with technology that enables longer dosing intervals and the company is proceeding with development of this engineered peptide as a monotherapy and as part of a…
That is the title of my paper out today in the Journal of Comparative Effectiveness Research written with co-authors Adam Kittai, Dipen Patel, Nadine Zawadzki, Vikram Shetty, Yazan Barqawi, and Joanna Rhodes. The abstract is below. Aim: To estimate cost savings associated with covalent Bruton’s tyrosine kinase inhibitor (cBTKi) choice in patients with treatment-naive (TN) and…
The future of telehealth is trust, combined with patient education. As the market matures, all parties — providers, regulators, and platforms — must collaborate to sustain that trust. The post Telehealth Fraud & Compliance: Preventing ‘Pill Mills’ While Ensuring Access to Care appeared first on MedCity News.
By MIKE MAGEE The leaders of America’s scientific community seem genuinely surprised by the actions of the past three weeks. They expected to be spared the wrath of Trump because they believed that “Americans of all political persuasions have respect for science and celebrate its breakthroughs.” Maybe so. But that is an inadequate defense against a…
Some large health systems are experimenting with selling their internal capabilities — such as IT support, revenue cycle management and call center operations — to smaller hospitals as a new revenue stream. While the approach is still rare, it has the potential to help health systems monetize their expertise and infrastructure, one healthcare consultant said….